Compounds > ranolazine
Page last updated: 2024-08-24

ranolazine and Cirrhosis

ranolazine has been researched along with Cirrhosis in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's3 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Alsina, KM; Chen, C; Duan, Q; He, M; Li, X; Ni, L; Nie, J; Wang, B; Wang, DW; Wehrens, XHT; Wen, Z; Wu, L; Zhou, C1
Alemanni, M; Altomare, C; Barile, L; Cornaghi, L; Gobbi, M; Latini, R; Lucchetti, J; Mostacciuolo, G; Rizzetto, R; Rocchetti, M; Ronchi, C; Russo, I; Sala, L; Staszewsky, LI; Zambelli, V; Zaza, A1
Belardinelli, L; Chi, L; Dhalla, AK; Hoyer, K; Liles, JT; Oliver, J1

Other Studies

3 other study(ies) available for ranolazine and Cirrhosis

ArticleYear
Ranolazine prevents pressure overload-induced cardiac hypertrophy and heart failure by restoring aberrant Na
    Journal of cellular physiology, 2019, Volume: 234, Issue:7

    Topics: Animals; Calcium; Cardiomegaly; Cardiovascular Agents; Cell Line; Fibrosis; Heart Failure; Hypertension; Male; Mice; Mice, Inbred C57BL; Myocytes, Cardiac; Random Allocation; Ranolazine; Sodium

2019
Ranolazine prevents INaL enhancement and blunts myocardial remodelling in a model of pulmonary hypertension.
    Cardiovascular research, 2014, Oct-01, Volume: 104, Issue:1

    Topics: Acetanilides; Animals; Calcium Signaling; Collagen; Disease Models, Animal; Fibrosis; Hypertension, Pulmonary; Hypertrophy, Right Ventricular; Male; Membrane Potentials; Monocrotaline; Myocytes, Cardiac; Myosin Heavy Chains; Piperazines; Pulmonary Artery; Ranolazine; Rats; Rats, Sprague-Dawley; Sodium; Sodium Channel Blockers; Sodium Channels; Time Factors; Vascular Remodeling; Vascular Resistance; Ventricular Function, Right; Ventricular Remodeling

2014
Ranolazine reduces remodeling of the right ventricle and provoked arrhythmias in rats with pulmonary hypertension.
    The Journal of pharmacology and experimental therapeutics, 2015, Volume: 353, Issue:3

    Topics: Acetanilides; Animals; Arrhythmias, Cardiac; Collagen; Electrocardiography; Enzyme Inhibitors; Fibrosis; Hypertension, Pulmonary; In Vitro Techniques; Piperazines; Ranolazine; Rats; Rats, Sprague-Dawley; Ventricular Remodeling

2015